The Moveable Feast: Nanotechnology on our Dinner Tables

Kevin Hurley

From genetically modified crops to nanoparticles in our food, converging technologies will likely change the way we eat. By converging technologies, we are referring to the convergence of Nanotechnology, Biotechnology, Information Technologies, and Cognitive Sciences (NBIC ). Genetically modified organisms (GMOs) already part of the legal landscape wiih Monsanto v.

Other Bioethics News

FUTURISM UPDATE (September 19, 2014)

FUTURISM UPDATE (September 19, 2014)
WALL STREET JOURNAL: It’s Time to Take Artificial Intelligence Seriously. No Longer an Academic Curiosity, It Now Has Measurable Impact on Our Lives http://online.wsj.com/articles/its-time-to-take-artificial-i.….1408922644
Blue Origin to Replace Russia’s RD-180 for U.S. Rocket Flights http://www.21stcentech.com/blue-origin-replace-russias-rd-18.….t-flights/
CBSNEWS: Popular Science picks best inventions for 2014 http://www.cbsnews.com/videos/popular-science...

Big Results Require Big Ambitions: Three young UCSB faculty receive CAREER awards from the National Science Foundation

Three UC Santa Barbara researchers — a computer scientist, a chemical engineer and a physicist — are among the recent recipients of the National Science Foundation's Faculty Early Career Development (...

CiQUS researchers design an artificial nose to detect DNA differentiation with single nucleotide resolution

As they have published in the prestigious journal Small, this is a method of identification of nucleic acids based on the generation pattern (bar code) inspired by our olfactory system. The difference...

Startup scales up graphene production, develops biosensors and supercapacitors

An official of a materials technology and manufacturing startup based on a Purdue University innovation says his company is addressing the challenge of scaling graphene production for commercial applications.

Graphene sensor tracks down cancer biomarkers

An ultrasensitive biosensor made from the wonder material graphene has been used to detect molecules that indicate an increased risk of developing cancer.

About Linda

LINDA MACDONALD GLENN, JD, LLM (Biomedical Ethics, McGill) is a healthcare ethics educator, attorney-at-law and a consultant. Currently an Assistant Professor at the Alden March Bioethics Institute, Albany Medical Center, she is also a Fellow at the Institute for Emerging Technologies. Her research encompasses the legal, ethical, and social impact of emerging technologies and evolving notions of personhood.more about Linda
Syndicate content